Core One Labs Inc. (CLABF) Research

Core One Labs Inc. operates as a life sciences and biotechnology firm, dedicated to research and development. Its core mission revolves around pioneering the introduction of psychedelic medicines to the commercial landscape. This is achieved through several strategic avenues: the development of innovative drug delivery systems, the practice of psychedelic-assisted psychotherapy, and the manufacturing of pharmaceutical-grade psilocybin. The company also boasts its proprietary CannaStrips technology, which enhances the bioavailability of cannabis compounds via infused strips. Complementing these activities, Core One Labs provides a suite of services including consulting, financial support, and micro-cultivation. It also manages medical and wellness facilities, offers natural health products, and engages in news distribution. Established in 2010, the Vancouver, Canada-based company adopted its current name, Core One Labs Inc., in September 2019, having previously operated as Lifestyle Delivery Systems Inc.

Market snapshot

Symbol
CLABF
Price
$0.00
Day change
0.00%
Market cap
$6.8M
P/E ratio
-0.28x
52-week range
0.00001-0.10575
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • Cann Group Limited (CNGGF)
  • Canntab Therapeutics Limited (CTABF)
  • Doseology Sciences Inc. (DOSEF)
  • Enzon Pharmaceuticals, Inc. (ENZN)
  • Evolutionary Genomics, Inc. (FNAM)
  • HAVN Life Sciences Inc. (HAVLF)
  • HealthLynked Corp. (HLYK)
  • Sigyn Therapeutics, Inc. (SIGY)

Open Core One Labs Inc. (CLABF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.